Data From Final Cohort Of Patients In Patrys Limited Multiple Myeloma Clinical Trial

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MELBOURNE, Australia--(BUSINESS WIRE)--Patrys Limited (ASX:PAB), a clinical stage biotechnology company has announced that updated results from its PAT-SM6 Phase I/IIa clinical trial in multiple myeloma (MM) will be presented at the 55th American Society of Hematology (ASH) Annual Meeting in New Orleans, LA on 7- 10 December 2013.

Help employers find you! Check out all the jobs and post your resume.

Back to news